TY  - GEN 
AU  - Cebey-López, M.
AU  - Currás Tuala, María José
AU  - Gomez Rial, Jose
AU  - Rivero Calle, Irene
AU  - Pardo Seco, Jacobo José
AU  - Méndez Gallart, Roberto
AU  - Pischedda, Sara
AU  - Gómez Carballa, Alberto
AU  - Barral-Arca, R.
AU  - Justicia Grande, Antonio José
AU  - Viz Lasheras, Sandra
AU  - Rodríguez-Tenreiro, C.
AU  - Gómez, R.
AU  - Salas Ellacuriaga, Antonio
AU  - Martinón-Torres, F.
PY  - 2022
SN  - 2296-2360
UR  - http://hdl.handle.net/20.500.11940/20746
AB  - Background: Progressive osseous heteroplasia (POH) is an ultrarare genetic disorder characterized by an inactivating mutation in the GNAS gene that causes heterotopic ossification. Inhibition of the mammalian target of the rapamycin (mTOR) signalling...
LA  - eng
TI  - Case Report: Everolimus reduced bone turnover markers but showed no clinical benefit in a patient with severe progressive osseous heteroplasia
DO  - 10.3389/fped.2022.936780
KW  - AS Santiago
KW  - IDIS
KW  - CHUS
KW  - CHUP
KW  - AS Pontevedra
VL  - 10
ER  -